Lucid Genomics

The company provides a long-read genome interpretation platform that processes raw sequencing data from PacBio HiFi and Oxford Nanopore into actionable clinical insights. The software automates variant calling, prioritization, and reporting for structural variants, repeat expansions, and methylation patterns. It serves clinicians and researchers in the healthcare and pharmaceutical sectors, specifically targeting rare disease diagnosis and genomic discovery.